Customized nutritional enhancement for pregnant women appears to lower incidence of certain common maternal and neonatal complications: an observational study

Leslie P Stone, P Michael Stone, Emily A Rydbom, Lucas A Stone, T Elliot Stone, Lindsey E Wilkens, Kathryn Reynolds, Leslie P Stone, P Michael Stone, Emily A Rydbom, Lucas A Stone, T Elliot Stone, Lindsey E Wilkens, Kathryn Reynolds

Abstract

A retrospective chart review analyzed the effect of customized nutrition on the incidence of pregnancy-induced hypertension (PIH), gestational diabetes (GDM), and small- and large-for-gestational-age (SGA, LGA) neonates, examining consecutive deliveries between January 1, 2011, and Decem ber 31, 2012, at a low-risk community hospital. The population was divided into 3 groups: (1) study group (SG), (2) private practice (PP), and (3) community healthcare clinic (CHCC). All groups received standard perinatal management, but additionally the study group was analyzed for serum zinc, carnitine, total 25-hydroxy cholecalciferol (25 OH-D), methylene tetrahydrofolate reductase, and catechol-O-methyl transferase polymorphisms in the first trimester prior to intervention, with subsequent second trimester and postpartum assessment of zinc, carnitine, and 25 OH-D after intervention. Intervention consisted of trimesterby-trimester nutrition and lifestyle education, supplementation of L-methyl folate, magnesium, essential fatty acids, and probiotics for all SG patients, with targeted supplementation of zinc, carnitine, and 25 OH-D. Because of small case occurrence rates of individual conditions in the study group, unreportable reductions were found, except GDM (SG vs CHCC, P value .046 with 95.38% confidence interval [CI]), and PIH (SG vs PP, P value .0505 with 94.95% CIl). The aggregated occurrence rate of the four conditions, however, was significantly lower in the study population than in either comparison population (PP P value .0154 with 98.46% CI, and CHCC P value .0265 with 97.35% CI). Customized nutritional intervention appears to have significantly reduced adverse perinatal outcomes. Prospective study within larger, at-risk populations is needed to determine whether customized nutrition improves conditions individually.

Keywords: Nutrition; neonatal complications; observational study; pregnancy.

References

    1. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291(21):2616–22.
    1. Scientific Advisory Committee on Nutrition (SACN) AccessedOctober22, 2014.
    1. Roseboom TJ, van der Meulen JH, Ravelli AC, Osmond C, Barker DJ, Bleker OP. Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview. Mol Cell Endocrinol. 2001;185(1–2):93–8.
    1. Lumey LH, Stein AD, Kahn HS, et al. Cohort profile: The Dutch Hunger Winter Families Study. Int J Epidemiol. 2007;36:1196–204.
    1. Robinson S. Introduction to early life and later disease. In: Nutrition and development: short and long term consequences for health. Report of the British Nutrition Foundation Task Force. Hoboken, NJ: Wiley-Blackwell; 2013:3–7.
    1. Dominguez-Salas P, Moore SE, Cole D, et al. DNA methylation potential: dietary intake and blood concentrations of one carbon metabolites and cofactors in African women. Am J Clin Nutr. 2013;97(6):1217–27.
    1. McCarthy MM, Auger AP, Bale TL, et al. The epigenetics of sex differences in the brain. J Neurosci. 2009;29(41):12815–23.
    1. Lohninger A, Radler U, Jinniate S, et al. Carnitine supplementation decreases rise in FFA, insulin resistance and gestational diabetes in pregnant women. Gynakol Geburtshilfliche Rundsch. 2009;49(40):230–5.
    1. Benton D. Micronutrient status, cognition, and behavioral problems in childhood. Eur J Nutr. 2008 Aug;47Suppl 3:38–50.
    1. Keller U, van der Wal C, Seliger G, Scheler C, Ropke F, Eder K. Carnitine status of pregnant women: effect of carnitine supplementation and correlation between iron status and plasma carnitine concentration. Eur J Clin Nutr. 2009;63(9):1098–105.
    1. Ringseis R, Hanisch N, Seliger G, Eder K. Low availability of carnitine precursors as a possible reason for the diminished carnitine concentrations in pregnant women. BMC Pregnancy Childbirth. 2010April25;10:17.
    1. King JC, Cousins RJ. Zinc. In: Modern nutrition in health and disease. 11th ed Baltimore, MD: Lippencott Williams & Wilkens; 2014:189–205.
    1. Benton D. Micronutrient status, cognition, and behavioral problems in childhood. Eur J Nutr. 2008;47Suppl 3:38–50.
    1. Mercer JG. Neurologic development. In: Nutrition and development: short and long term consequences for health. Hoboken, NJ: Wiley-Blackwell; 2013:97–115.
    1. Buttriss JL, Stanner SA, Sanders TB. Putting the science into practice: public health implications. In: Nutrition and development: short and long term consequences for health. Hoboken, NJ: Wiley-Blackwell; 2013:232–4.
    1. Ly NP, Litonjua A, Gold DR, Celedon JC. Gut microbiota, probiotics, and vitamin D. J Allergy Clin Immunol. 2011;127(5):1087–94.
    1. Kuitunen M. Probiotics and prebiotics in preventing food allergy and eczema. Curr Opin Allergy Clin Immunol. 2013;13(3):280–6.
    1. McCartney A. Establishing of gut microbiota and bacterial colonization of the gut in early life. In: Nutrition and development: short and long term consequences for health. Hoboken, NJ: Wiley-Blackwell; 2013:116–29.
    1. Forsberg A, Abrahamsson TR, Bjorksten B, Jenmalm MC. Pre- and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy. 2013;43(4):434–42.
    1. Schmidt RJ, Nansen RL, Hartiala J, et al. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology. 2011;22(4):476–85.
    1. Grandone E, Margaglione M, Colaizzo D, et al. Prothrombotic genetic risk factors and occurrence of gestational hypertension with and without proteinuria. Thromb Haemost. 1999;81(3):349–52.
    1. Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab. 2002;13(9):364–8.
    1. Morse NL. Benefits of docosahexaenoic acid, folic acid, vitamin D and iodine on foetal and infant brain development and function following maternal supplementation during pregnancy and lactation. Nutrients 2012;4(7):799–840.
    1. Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States are the health consequences underestimated? Nutr Rev. 2012 Mar;70(3):153–64 doi: 10.1111/j.1753-4887.2011.00465.x.Epub2012February15
    1. Ames BN. A role for supplements in optimizing health: the metabolic tune-up. Arch Biochem Biophys. 2004;423(1):227–34.
    1. Ames BN. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. PNAS. 2006;103(47);17589–94.
    1. Ward E. Addressing nutritional gaps with multivitamin and mineral supplements. Nutr J. 2014 Jul 15;13: 72.
    1. Kaati G, Bygren LO, Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur J Hum Genet. 2002;10(11):682–8.
    1. Schmidt CW. Uncertain inheritance: transgenerational effects of environmental exposures. Env Health Perspetives 2013;121(10):A298–303.
    1. Blegen MB, Kennedy BC, Thibert KA, Gewirtz JC, Tran PV, Georgieff MK. Multi-generational effects of fetal-neonatal iron deficiency on hippocampal BDNF signaling. Phys Reports. 2013;1(5):e0096.
    1. Nicoletto SF, Rinaldi A. In the womb's shadow: the theory of prenatal programming as the fetal origin of various adult diseases is increasingly supported by a wealth of evidence. EMBO Rep. 2011January;12(1):30–4.
    1. Bertram C, Khan O, Ohri S, Phillips DI, Matthews SG, Hanson MA. Transgenerational effects of prenatal nutrient restriction on cardiovascular and hypothalamic-pituitary-adrenal function. J Physiol. 2008;586(8).8:2217–29.
    1. Burdge GC, Hoile SP, Uller T, et al. Progressive, transgenerational changes in offspring phenotype and epigenotype following nutritional transition. PLoS ONE. 2011;6(11):e28282.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi